Form D
View Original Filing
Notice of Exempt Offering of Securities
Item 1. Issuer's Identity
Name of Issuer:
MPM BIOVENTURES 2018, L.P.
Jurisdiction of Incorporation/Organization
DELAWARE
Year of Incorporation/Organization
2017
Entity Type
LIMITED PARTNERSHIP
Item 2 Issuer Principal Place of Business and Contact Information
450 KENDALL STREET
CAMBRIDGE, MA 02142
Phone Number:
subscription required
Item 3. Related Persons
Name
N/A MPM BIOVENTURES 2018 GP LLC
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- PROMOTER
Clarification of Response
THE GENERAL PARTNER OF THE ISSUER.
Item 3. Related Persons
Name
ANSBERT GADICKE
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- PROMOTER
Clarification of Response
DR. GADICKE IS THE PRINCIPAL MANAGING DIRECTOR OF THE MANAGING MEMBER OF THE GENERAL PARTNER OF THE ISSUER.
Item 3. Related Persons
Name
LUKE EVNIN
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- PROMOTER
Clarification of Response
MR. EVNIN IS THE PRINCIPAL MANAGING DIRECTOR OF THE MANAGING MEMBER OF THE GENERAL PARTNER OF THE ISSUER.
Item 3. Related Persons
Name
TODD FOLEY
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- PROMOTER
Clarification of Response
MR. FOLEY IS THE MANAGING DIRECTOR OF THE MANAGING MEMBER OF THE GENERAL PARTNER OF THE ISSUER.
Item 3. Related Persons
Name
ED HURWITZ
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- PROMOTER
Clarification of Response
MR. HURWITZ IS THE MANAGING DIRECTOR OF THE MANAGING MEMBER OF THE GENERAL PARTNER OF THE ISSUER.
Item 4. Industry Group
POOLED INVESTMENT FUND
- VENTURE CAPITAL FUND
Item 5. Issuer Size
Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE
Item 6. Federal Exemptions and Exclusions Claimed
Item 7. Type of Filing
New Notice
Date of First Sale in this Offering:
First Sale Yet to Occur
Item 8. Duration of Offering
Does the issuer intend this offering to last more than one year?
No
Item 9. Type(s) of Securities Offered
- Pooled Investment Fund Interests
- Other: LIMITED PARTNERSHIP INTERESTS
Item 10. Business Combination Transaction
Is this offering being made in connection with a business combination
transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response
Item 11. Minimum Investment
Minimum Investment accepted from any outside investor
0
Item 13. Offering and Sales Amounts
Total Offering Amount
400000000
Total Amount Sold
0
Total Remaining to be Sold
400000000
Clarification of Response
THE AGGREGATE TOTAL OFFERING AMOUNT OF THE ISSUER AND ITS AFFILIATED FUND, MPM BIOVENTURES 2018 (B), L.P. WILL BE $400,000,000. THE AMOUNTS REFLECTED IN THIS FORM D ARE ONLY FOR THE ISSUER.
Item 14. Investors
Securities in the offering have been or may be sold to persons
who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
0
Item 15. Sales Commissions and Finders' Fees Expenses
Sales Commissions:
0.0
Finders' Fees
0.0
Clarification of Response
Item 16. Use of Proceeds
Provide the amount of the gross proceeds of the offering
that has been or is proposed to be used for payments to any of the persons required
to be named as executive officers,directors or promoters in response to Item 3 above.
0.0 Is an estimate
Clarification of Response
CERTAIN PERSONS NAMED IN ITEM 3 OR AFFILIATE(S) THEREOF MAY RECEIVE PAYMENTS DEEMED TO BE MADE FROM THE PROCEEDS OF THE OFFERING, INCLUDING MANAGEMENT FEES. THE AMOUNT OF SUCH PAYMENTS CANNOT BE ESTIMATED AT THIS TIME.
Signature and Submission
Issuer Name
MPM BIOVENTURES 2018, L.P.
Issuer Signature
/S/ ANSBERT GADICKE
Signer Name
ANSBERT GADICKE
Signer Title
PRINCIPAL MAN DIR OF MAN MEM OF GP OF THE ISSUER
Signature Date
02/22/2018